The Anti-money Laundering Act of 2020 Presents…
We provide clients with a view of market trends that may cause disruption to their business, and help them make enlightened decisions to direct future investment in transformative innovation. We constantly assess the delta between existing assets and requirements to deliver customer needs.
The ventures focused on key under-addressed markets such as the global ageing segment, fem-tech, and taboo markets.
The consumer health divisions of large corporates such as J&J, GSK, Bayer, and Reckitt Benckiser are facing unprecedented competition with the rise of startup e-commerce and telehealth businesses, which are in line with current consumer unmet needs, and are capturing consumers through better a user experience. In parallel, under-addressed markets such as ageing consumers (50+), feminine care, and taboo markets, present significant growth opportunities globally.
Our challenge was to identify these under-addressed markets (such as: sleep improvement, sexual health, teenage health, and the ageing market segment) and build data-centric ventures to reach the target audience through direct-to-consumer channels. Working closely with our client, we piloted a venture focused on helping women through the symptoms of menopause.
Our approach combined the following activities to identify the right strategic ventures to build, test and launch. We particularly emphasized the importance of human-centric testing, to understand the major symptoms, key unmet needs and pain points of consumers.
Sia Partners focused on turning strategic insights into tangible outcomes in the market. The results of the partnership with J&J included: